Artica Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $12M

  • Investors
  • 5

Artica Therapeutics General Information

Description

Developer of novel therapies intended to treat severe autoimmune and inflammatory disorders. The company provides label-free cellular-based screening approaches to allow rapid progression of drug candidates, enabling healthcare professionals to have selective therapies for patients with unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Biopartner 4
  • Robert Boyleweg 4
  • 2333 CG Leiden
  • Netherlands
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • Biopartner 4
  • Robert Boyleweg 4
  • 2333 CG Leiden
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Artica Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 02-Nov-2023 $12M Completed Generating Revenue
1. Seed Round 01-Jan-2021 Completed Generating Revenue
To view Artica Therapeutics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Artica Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel therapies intended to treat severe autoimmune and inflammatory disorders. The company provides label-
Drug Discovery
Leiden, Netherlands

Belfast, United Kingdom
 

Rotterdam, Netherlands
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Artica Therapeutics Competitors (2)

One of Artica Therapeutics’s 2 competitors is CV6 Therapeutics, a Venture Capital-Backed company based in Belfast, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CV6 Therapeutics Venture Capital-Backed Belfast, United Kingdom
Numeric Biotech Private Debt Financed Rotterdam, Netherlands
You’re viewing 2 of 2 competitors. Get the full list »

Artica Therapeutics Patents

Artica Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2023031308-A1 Ccr2 inhibitors Inactive 31-Aug-2021

Artica Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
InnovationQuarter Venture Capital Minority
Mibiton Venture Capital Minority
Seroba Life Sciences Venture Capital Minority
Thuja Capital Management Venture Capital Minority
BioGeneration Ventures Venture Capital Minority
To view Artica Therapeutics’s complete investors history, request access »

Artica Therapeutics FAQs

  • When was Artica Therapeutics founded?

    Artica Therapeutics was founded in 2020.

  • Where is Artica Therapeutics headquartered?

    Artica Therapeutics is headquartered in Leiden, Netherlands.

  • What industry is Artica Therapeutics in?

    Artica Therapeutics’s primary industry is Drug Discovery.

  • Is Artica Therapeutics a private or public company?

    Artica Therapeutics is a Private company.

  • What is Artica Therapeutics’s current revenue?

    The current revenue for Artica Therapeutics is .

  • How much funding has Artica Therapeutics raised over time?

    Artica Therapeutics has raised $12M.

  • Who are Artica Therapeutics’s investors?

    InnovationQuarter, Mibiton, Seroba Life Sciences, Thuja Capital Management, and BioGeneration Ventures have invested in Artica Therapeutics.

  • Who are Artica Therapeutics’s competitors?

    CV6 Therapeutics and Numeric Biotech are competitors of Artica Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process